Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis

scientific article published on 28 July 2008

Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/ARD.2008.091967
P698PubMed publication ID18662929

P50authorIain McInnesQ41687181
Susan S JickQ42946335
P2093author name stringL Li
N Sattar
H Choi
P433issue4
P407language of work or nameEnglishQ1860
P921main subjecthyperlipidemiaQ1079120
rheumatoid arthritisQ187255
P304page(s)546-551
P577publication date2008-07-28
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titleHyperlipidaemia, statin use and the risk of developing rheumatoid arthritis
P478volume68

Reverse relations

cites work (P2860)
Q37728928A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis
Q49387323A validation study of the CirCom comorbidity score in an English cirrhosis population using the Clinical Practice Research Datalink.
Q34344584Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis
Q33943374Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment
Q37829385Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy
Q38220638Defining populations at risk of rheumatoid arthritis: the first steps to prevention
Q37690217Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration
Q55515189Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease.
Q33696612Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database
Q34901953LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study
Q38026796Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies
Q35762538Modifiable risk factors for RA: prevention, better than cure?
Q55305262PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders.
Q52688337Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink.
Q33691624Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study
Q33890221Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation
Q41466368Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment
Q37472928Role for TNF in atherosclerosis? Lessons from autoimmune disease
Q35023243Statin use and markers of immunity in the Doetinchem cohort study
Q38404891Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study
Q37795294Statins and the Joint: Multiple Targets for a Global Protection?
Q31139441The Use of a Bayesian Hierarchy to Develop and Validate a Co-Morbidity Score to Predict Mortality for Linked Primary and Secondary Care Data from the NHS in England
Q37909189The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review
Q85069909Therapy of dyslipidemia in rheumatic diseases
Q34411415Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
Q33867311Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

Search more.